Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acclarent, a developer and marketer of medical devices, has closed a $26 million financing round.
Subscribe to our email newsletter
Acclarent intends to use the proceeds to continue commercialization of its Balloon Sinuplasty technology, as well as on-going investment in product development and clinical studies.
Johnson & Johnson Development joined existing prominent investors New Enterprise Associates, Delphi Ventures, Versant Ventures, and Meritech Capital Partners in this financing.
Bill Facteau, president and CEO of Acclarent, said: “The addition of Johnson & Johnson Development together with the support of our existing financial partners will enable Acclarent to continue executing on our strategy to build the preeminent ENT Company.”